Omega-3 fatty acid supplementation decreases matrix metalloproteinase-9 production in relapsing-remitting multiple sclerosis,
- 1 February 2009
- journal article
- clinical trial
- Published by Elsevier BV in Prostaglandins, Leukotrienes & Essential Fatty Acids
- Vol. 80 (2-3), 131-136
- https://doi.org/10.1016/j.plefa.2008.12.001
Abstract
No abstract availableThis publication has 51 references indexed in Scilit:
- Neutralizing anti-interferon beta antibodies are associated with reduced side effects and delayed impact on efficacy of Interferon-betaMultiple Sclerosis Journal, 2007
- Anti-inflammatory Effect of Docosahexaenoic Acid on Cytokine-Induced Adhesion Molecule Expression in Human Retinal Vascular Endothelial CellsInvestigative Ophthalmology & Visual Science, 2005
- Anti-inflammatory effects of polyunsaturated fatty acids in THP-1 cellsBiochemical and Biophysical Research Communications, 2005
- Eicosapentaenoic acid prevents lipopolysaccharide-stimulated DNA binding of activator protein-1 and c-Jun N-terminal kinase activityThe Journal of Nutritional Biochemistry, 2005
- Pathologic indicators of degradation and inflammation in human osteoarthritic cartilage are abrogated by exposure to n‐3 fatty acidsArthritis & Rheumatism, 2002
- Recent developments in the assessment of quality of life in Multiple Sclerosis (MS)Multiple Sclerosis Journal, 1999
- Side effect profile and adherence to in the treatment of Multiple Sclerosis with interferon beta-laMultiple Sclerosis Journal, 1998
- Copolymer 1 reduces relapse rate and improves disability in relapsing‐remitting multiple sclerosisNeurology, 1995
- Immunological Aspects of Demyelinating DiseasesAnnual Review of Immunology, 1992
- Rating neurologic impairment in multiple sclerosisNeurology, 1983